ClinicalTrials.Veeva

Menu

The Role of Netrin -1 in Acute Coronary Syndrome (ACS-NETRİN-1)

A

Aksaray University Training and Research Hospital

Status

Completed

Conditions

Acute Coronary Syndrome

Treatments

Other: netrin-1 value on admission to hospital

Study type

Interventional

Funder types

Other

Identifiers

NCT04027127
aksaray 2013-23

Details and patient eligibility

About

In our study, Netrin -1; We found that patients with ACS increased at the time of admission, decreased TIMI 3 flow after angiography, and higher risk groups in high risk groups such as TIMI and GRACE were found to have higher Netrin-1 levels.

Enrollment

238 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients over the age of 18
  • diagnose ACS
  • patients undergoing angiography

Exclusion criteria

  • CVE history
  • Neurological disease
  • Pregnancy and Lactation
  • Liver failure
  • Diagnosed malignity
  • Use of anticonvulsant and nephrotoxic medication
  • Chronic kidney disease
  • Not having angiography
  • Developing acute renal failure after angiography
  • Patients who rejected to participate were excluded.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

238 participants in 2 patient groups

ACS GRUP
Active Comparator group
Description:
Demographic characteristics, history, vital signs, laboratory findings, coronary angiography (CAG) and echocardiography (ECO) findings of the patients were recorded. Netrin-1 levels were studied with blood collected at the hospital and 6-8 hours after CAG. CAG results were evaluated by TIMI flow. The patients were divided into two groups with and without TIMI 3 flow and Netrin-1 levels were compared. GRACE (Global Registry of Acute Coronary Events) and TIMI (Thrombolysis in Myocardial Ischemia) clinical risk assessments were performed and Netrin-1 values were compared.
Treatment:
Other: netrin-1 value on admission to hospital
plasebo grup
Active Comparator group
Description:
It consisted of those without any disease and netri-1 values at admission were compared with the uptake patient group.
Treatment:
Other: netrin-1 value on admission to hospital

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems